|
ZFP112 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.18639999999471E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.77390000039624E-07 |
| Normal-vs-Stage2 |
1.82680999999407E-05 |
| Normal-vs-Stage3 |
3.7110999999701E-06 |
| Normal-vs-Stage4 |
6.6598000003637E-07 |
| Stage1-vs-Stage2 |
5.201600E-01 |
| Stage1-vs-Stage3 |
4.344200E-01 |
| Stage1-vs-Stage4 |
1.942050E-02 |
| Stage2-vs-Stage3 |
9.696000E-01 |
| Stage2-vs-Stage4 |
3.151400E-01 |
| Stage3-vs-Stage4 |
2.310000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.24709999999229E-07 |
| Normal-vs-AfricanAmerican |
5.73339999999645E-05 |
| Normal-vs-Asian |
2.061300E-03 |
| Caucasian-vs-AfricanAmerican |
4.257000E-01 |
| Caucasian-vs-Asian |
7.960000E-01 |
| AfricanAmerican-vs-Asian |
3.386600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0949999795784E-09 |
| Normal-vs-Female |
3.175300E-03 |
| Male-vs-Female |
1.858500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.386800E-04 |
| Normal-vs-Extreme_Weight |
3.71910002794351E-09 |
| Normal-vs-Obese |
1.55176999999673E-05 |
| Normal-vs-Extreme_Obese |
2.727700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.458630E-01 |
| Normal_Weight-vs-Obese |
7.897800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.156400E-01 |
| Extreme_Weight-vs-Obese |
1.196400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.731800E-01 |
| Obese-vs-Extreme_Obese |
6.496400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.84829999999981E-05 |
| Normal-vs-Age(41-60Yrs) |
1.72301999999958E-05 |
| Normal-vs-Age(61-80Yrs) |
8.94689999864084E-08 |
| Normal-vs-Age(81-100Yrs) |
1.84859999996512E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.631600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.867800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.308000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.496100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.042030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.441800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.63470000553212E-08 |
| Normal-VS-Type2 PRCC |
2.15980011653016E-10 |
| Normal-VS-KIRP CIMP |
1.568150E-04 |
| Normal-VS-Unclassified PRCC |
5.236000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.182900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.417000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.945600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.769200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.113700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.988010E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.11609968331561E-10 |
| Normal-vs-N1 |
8.12359999999845E-05 |
| Normal-vs-N2 |
2.20649999999045E-05 |
| N0-vs-N1 |
1.888580E-01 |
| N0-vs-N2 |
7.432400E-02 |
| N1-vs-N2 |
4.213600E-02 |
|
|
